SAN RAMON, Calif., September 14, 2022 — With digital device use putting more demands on the eyes than ever before, CooperVision announced today an addition to its product portfolio: MyDay Energys® daily disposable contact lenses. MyDay Energys® is the first 1 day contact lens with an innovative single vision aspheric lens design, which was initially introduced in the company’s groundbreaking Biofinity Energys®. The lenses are designed for today’s world, providing extraordinary comfort for wearers when they are using digital devices.
Today’s teens report spending more than eight hours a day on screens1 and adults more than 11 hours a day on digital devices.2 Plus, more than 67% of adults report using two or more devices simultaneously.3 These activities can contribute to eyes feeling strained and uncomfortable.4
“Extensive digital device use—and the resulting discomfort of digital eye strain5—have become part of everyday life,” said Michele Andrews, OD, Vice President, Professional and Government Affairs, Americas, CooperVision. “In the years since CooperVision launched Biofinity Energys® to help eye care professionals address these challenges, we’ve consistently been asked for the same technology in a 1 day lens. Through our commitment to continuous innovation and a relentless vision to grow the value of contact lenses for fitters and patients, that day will be here soon.”
MyDay Energys® is the latest addition to CooperVision’s popular MyDay® family. MyDay® contact lenses are made with Aquaform® Technology, which provides a unique balance of high oxygen permeability, a naturally wettable material, and optimum modulus for increased breathability and moisture in a soft, flexible lens. The lens also provides ease of insertion and built-in UV blocking (86% of UVA and 97% of UVB rays*), helping to minimize the transmission of harmful UV rays.
The introduction of MyDay Energys® is the latest advancement in the company’s commitment to providing CooperVision’s innovative lens features across both the monthly and 1 day modalities.
Further details regarding MyDay Energys®, including available parameters and U.S. availability, will be announced in the coming months.
# # #
1. Common Sense Media. 2021. The Common Sense Census Media Use by Tweens and Teens.
2. The Nielsen Company, The Nielsen Total Audience Report, https://www.nielsen.com/wp-content/uploads/sites/3/2019/04/q1-2018-total-audience-report.pdf.
3. Vision Council 2019. The Vision Council shines light on protecting sight and health in a multiscreen era. https://thevisioncouncil.org/blog/vision-council-shines-light-protecting-sight-and-health-multi-screen-era. Accessed 19 July 2022.
4. Chantal Coles‐Brennan et al. Management of digital eye strain. Clinical and Experimental Optometry. 2019;(102)1:18-29.
5. Coles-Brennan C, Sulley A, Young G. Management of digital eye strain. Clinical and Experimental Optometry. 2019;102(1):18-29.
*Warning: UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. Patients should continue to use UV-absorbing eyewear as directed.
About CooperVision
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Media Contact
Heather Kowalczyk, APR
McDougall Communications for CooperVision
(585) 434-2148 or heather@mcdougallpr.com